Home    Back

Antiplatelets    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
124Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy1

124. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy    [ 11 clinical trials,   13 drugs,   (DrugBank: 4 drugs),   3 drug target genes,   11 drug target pathways]
Searched query = "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", "CADASIL", "Autosomal dominant cerebral artery disease with subcortical infarct and leukoencephalopathy", "Autosomal dominant cerebral artery disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 11 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01361763
(ClinicalTrials.gov)		June 201116/5/2011Safety Study of Dabigatran in CADASILPhase II, Randomized, Crossover, Single Blind, Safety Trial of DABIGATRAN Versus ASA for Preventing Ischaemic Brain Lesions in Patients Affected by CADASILCADASILDrug: Dabigatran;Drug: AntiplateletsS. Andrea HospitalNULLRecruiting18 YearsN/ABoth50Phase 2Italy